Table 3.
Univariate And Multivariate Analysis Of Overall Survival In 133 HCC Patient Samples
| Variables | Univariate Analysis | Multivariate Analysis | ||||
|---|---|---|---|---|---|---|
| P value | Hazard Ratio | 95% CI | P value | Hazard Ratio | 95% CI | |
| CCT6A scores | 0.021 | 1.139 | 1.02–1.273 | 0.037 | 1.113 | 1.007–1.231 |
| Gender | 0.691 | 1.154 | 0.568–2.344 | |||
| Age(years) | 0.65 | 1.126 | 0.676–1.875 | |||
| Tumor size(cm) | 0.022 | 2.261 | 1.122–4.555 | 0.524 | 1.3 | 0.580–2.911 |
| Tumor number | 0.001 | 2.606 | 1.478–4.592 | 0.355 | 1.7 | 0.553–5.232 |
| Encapsulation | 0.002 | 0.615 | 0.452–0.837 | 0.224 | 0.665 | 0.345–1.282 |
| Metastasis | 0.001 | 3.281 | 1.65–6.525 | 0.295 | 1.831 | 0.59–5.679 |
| Cirrosis | 0.124 | 1.747 | 0.857–3.558 | |||
| Tumor thrombus | <0.001 | 4.236 | 2.093–8.573 | 0.227 | 1.739 | 0.708–4.268 |
| Differentiation grade | 0.819 | 1.094 | 0.505–2.372 | |||
| Ascites | 0.071 | 1.987 | 0.942–4.189 | |||
| HBsAg | 0.832 | 0.918 | 0.416–2.026 | |||
| HBeAg | 0.283 | 1.653 | 0.66–4.142 | |||
| AFP(ng/mL) | <0.001 | 1 | 1 | 0.917 | 1.033 | 0.567–1.881 |
| PT(s) | 0.375 | 0.974 | 0.92–1.032 | |||
| ALT(U/L) | 0.212 | 1.008 | 0.996–1.019 | |||
| AST(U/L) | <0.001 | 1.028 | 1.017–1.04 | 0.002 | 1.021 | 1.008–1.034 |
| TNM stage | <0.001 | 1.696 | 1.376–2.09 | 0.556 | 1.446 | 0.423–4.939 |
| Recurrence | 0.01 | 1.982 | 1.176–3.34 | 0.286 | 1.39 | 0.759–2.548 |
| PLT(109/L) | 0.348 | 1.002 | 0.998–1.006 | |||
| Albumin(g/L) | 0.034 | 0.941 | 0.889–0.995 | 0.171 | 0.961 | 0.908–1.017 |
| Bilirubin(umol/L) | 0.117 | 1.031 | 0.992–1.071 | |||
| Cr | 0.911 | 1.001 | 0.987–1.015 | |||